News

CancerLinQ prototype leverages 'Big Data'

Publish date: April 2, 2013

 

mschneider@frontlinemedcom.com

Twitter @MaryEllenNY

Pages

Recommended Reading

Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32
MDedge Hematology and Oncology
A randomized, double-blind, placebo-controlled study of oral coenzyme Q 10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer
MDedge Hematology and Oncology
Direct access to unexpected genetic test results
MDedge Hematology and Oncology
Imaging agent approved for locating lymph nodes
MDedge Hematology and Oncology
Lipid metabolism genes linked to breast cancer subtype
MDedge Hematology and Oncology
Breast cancer: Cardiac risk increases with radiation dose to heart
MDedge Hematology and Oncology
Contralateral prophylactic mastectomy adds complications
MDedge Hematology and Oncology
Trastuzumab emtansine in advanced HER2-positive breast cancer
MDedge Hematology and Oncology
Treatment patterns in HER2-/HR-positive postmenopausal women with metastatic breast cancer initiating first-line treatment in a community oncology setting in the US
MDedge Hematology and Oncology
Community Oncology Podcast: T-DM1 in HER-2 positive breast cancer
MDedge Hematology and Oncology

Related Articles